Xiidra® (lifitegrast ophthalmic solution) 5% Savings

dry eye
- Inflammation in Dry Eye
  Inflammation is an underlying cause of dry eye disease.
- Symptoms and Risk Factors
  Common dry eye disease symptoms and risk factors.
- Patient Case Studies
  Identify inflammation in these hypothetical case studies.
moa
efficacy
- Pivotal Data
  12-week pivotal data results.
- Contact Lens Data
  Single-center, prospective, open-label study of 40 patients.
- Cataract Data
  Multicenter, prospective study of 100 eyes of 100 patients.
safety
- Adverse Events
  Common reported adverse events.
- Discontinuation Rates
  Pooled analysis of four 12-week studies.
- Long-Term Safety Data
  Most frequent adverse events reported in the 12-month study.
access
- Formulary Tool
  Find formulary coverage in your area.
- Patient Savings
  Copay savings program.
- BlinkRx
  Assistance with prior authorization and more.
resources
- Videos
  Hear from leading eye care professionals.
- Downloads
  Downloadable resources for getting patients their Xiidra Rx.
- Request Xiidra
  Order Xiidra samples for your office and get in contact with a rep.
- FAQs
  Frequently asked questions.
sign up
REQUEST A REP

ELIGIBLE COMMERCIAL Patients may pay as little as

with the Xiidra copay card or through BlinkRx^†

Need to enroll your patient for a copay card?

Help your patients get started with the Xiidra My Saviings Program by having them register for a copay card or activate an existing card at xiidra.blsavingscard.com

Additional questions about cost and affordability?

For more on helping patients start and stay on Xiidra and information on the Xiidra My Saviings Program for eligible commercial patients, please call the copay program support line at 1-877-4XiiDRA (1-877-494-4372)

We’ve got you and your patients covered

Xiidra is covered for 82% of dry eye
patients nationwide*

Commercial

Xiidra is covered for 78% of commercial patients*
85% of covered commercial patients do not require step therapy*

Medicare Part D

Xiidra is covered for 74% of Medicare patients*
94% of covered Medicare patients do not require prior authorization*

Uninsured

Patients may pay no more than $225 with the Xiidra copay card or through BlinkRx^‡

There are additional ways to help patients save

BlinkRx assists with prior authorizations and more, offering a seamless experience for your patients

Prior Authorization Support

BlinkRx services provide prior authorization support for Xiidra prescriptions, should your patients’ insurance require it

Low Price

BlinkRx works with your eligible commercially insured patients’ insurance and applies available savings to their Xiidra prescription, with no co-pay card needed

Free and Fast Delivery

BlinkRx delivers Xiidra prescriptions for free from one of their licensed network pharmacies around the country

Simple Patient Experience

BlinkRx will send patients a text with the lowest available price so that they can immediately purchase their Xiidra prescription online or over the phone

Ample Stocking

BlinkRx services the entire country, making Xiidra accessible for all patients

Dedicated Customer Support

BlinkRx has a team of pharmacists and technicians who are available to support you, your team, and your patients from onboarding to adherence

Want to learn more about BlinkRx?

Find a helpful guide and additional downloadable resources

START HERE

Making Xiidra more accessible across  coverage types

Prescribe through BlinkRx or provide your patients with the Xiidra copay card^§ for use at retail pharmacies to receive the following benefits:

COMMERCIALLY INSURED

Coverage Status	First Fill	Refills
	COMMERCIALLY INSURED
Covered	$0 (30/60/90-day supply)	$0 (30/60/90-day supply)
Not Covered	$0 (30-day supply)	$0 if prior authorization is approved (30/60/90-day supply) If prior authorization is submitted and denied: $79 for 30-day supply If prior authorization is not submitted: $225

Coverage Status

First Fill

Refills

COMMERCIALLY INSURED

Covered

$0
(30/60/90-day supply)

Not Covered

$0
(30-day supply)

$0 if prior authorization is approved (30/60/90-day supply)

If prior authorization is submitted and denied: $79 for 30-day supply

If prior authorization is not submitted: $225

PLEASE NOTE:
- Commercially insured patients with a high deductible or a high copay may pay ~$79 per 30-day supply and subsequent refills until deductible and/or out-of-pocket maximum is met.
- Copay card at Retail: Prior authorization must be submitted through PARx for patient to be eligible for Xiidra at $79.
- BlinkRx: Prior authorizations can be submitted through CoverMyMeds or PARx for patient to be eligible for Xiidra at $79.

GOVERNMENT INSURED

Coverage Status	First Fill	Refills
	GOVERNMENT INSURED
Covered^ǁ	Plan copay (30/60/90-day supply)	Plan copay (30/60/90-day supply)
Not Covered	If prior authorization is approved, plan copay	If prior authorization is approved, plan copay

EXCLUSIVELY THROUGH BLINKRx:
Eligible patients may pay a reduced cash price of $225 for Xiidra. Patients voluntarily choose to pay cash and not submit the prescription claim to their Medicare plan for the remainder of the calendar year.

UNINSURED, NON-GOVERNMENT

Coverage Status	First Fill	Refills
Cash Pay	$225 (30-day supply)	$225 (30-day supply)

^§Terms and conditions apply. See Eligibility Criteria and Terms and Conditions at xiidra.blsavingscard.com.

^ǁCopay card is not applicable for covered government patients.

Is your patient experiencing financial hardship?

For patients who have limited or no prescription coverage, contact the Bausch + Lomb Patient Assistance Program at 855-770-0424 or visit www.patientassistance.bausch.com. Patients who are eligible may receive their medication for free

GET STARTED WITH
BLINKRx

Being proactive in the prior authorization process may help improve your patients’ success with Xiidra

BEGIN HERE

Help Patients Start and Stay on Xiidra

Send patients home with the materials they need for a smooth onboarding process

DOWNLOAD NOW

*Based on MMIT data from January 2026.

^†Offer not valid for patients whose prescriptions are reimbursed by any federal or state healthcare program, including Medicaid, Medicare, TRICARE, or any other federal or state healthcare program. Other restrictions apply. See complete Eligibility Criteria and Terms and Conditions at xiidra.blsavingscard.com.

^‡For patients under the age of 65.

Indication

Xiidra® (lifitegrast ophthalmic solution) 5% is indicated for the treatment of signs and symptoms of dry eye disease (DED).

Important Safety Information

Xiidra is contraindicated in patients with known hypersensitivity to lifitegrast or to any of the other ingredients.
In clinical trials, the most common adverse reactions reported in 5-25% of patients were instillation site irritation, dysgeusia and reduced visual acuity. Other adverse reactions reported in 1% to 5% of the patients were blurred vision, conjunctival hyperemia, eye irritation, headache, increased lacrimation, eye discharge, eye discomfort, eye pruritus and sinusitis.
To avoid the potential for eye injury or contamination of the solution, patients should not touch the tip of the single-use container to their eye or to any surface.
Contact lenses should be removed prior to the administration of Xiidra and may be reinserted 15 minutes following administration.
Safety and efficacy in pediatric patients below the age of 17 years have not been established.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Click here for full Prescribing Information for Xiidra.

ACCESS

ELIGIBLE COMMERCIAL Patients may pay as little as

Need to enroll your patient for a copay card?

Additional questions about cost and affordability?